7,581.71

-138.68

-1.80%

51,871.49

-471.07

-0.90%

25,417.83

-766.89

-2.93%

2,809.69

-49.53

-1.73%

4.9470

-0.0420

-0.84%

19.96

+2.76

+16.05%

3,905.60

-125.80

-3.12%

77,194.78

-3,978.25

-4.90%

Crude Oil Dec 26

104.08

+2.08

+2.04%

US Private Equity

10,932.82

-7.68

-0.07%

XETRA - Delayed Quote EUR

Bayer Aktiengesellschaft (BAYN.DE)

50.22 +2.26 (+4.71%)

At close: 5:29:59 PM GMT+1

Loading Chart for BAYN.DE

Chart Range Bar

Interval:

In partnership with ChartIQ

Global Molecular Breeding Market Opportunities and Strategies to 2035 | Capitalize on Genomic Selection as Bayer, Syngenta, Corteva and BASF Drive a $21.55 Billion Market

Global Molecular Breeding Market Opportunities and Strategies to 2035 | Capitalize on Genomic Selection as Bayer, Syngenta, Corteva and BASF Drive a $21.55 Billion Market

Global Spray-Induced Gene Silencing (SIGS) Carrier Adjuvant Market Report 2026 | Capitalize on 9% CAGR Through 2030 as BASF, Bayer, Corteva and GreenLight Advance RNA Delivery

Global Spray-Induced Gene Silencing (SIGS) Carrier Adjuvant Market Report 2026 | Capitalize on 9% CAGR Through 2030 as BASF, Bayer, Corteva and GreenLight Advance RNA Delivery

US jury hands win to Bayer in weedkiller cancer case

US jury hands win to Bayer in weedkiller cancer case

Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

Bayer Shares Rise After Win in First Roundup Trial Since Supreme Court Ruling

Bayer Shares Rise After Win in First Roundup Trial Since Supreme Court Ruling

What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call

What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call

BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates

BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates

Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?

Orion Q3 operating profit beats forecasts as Nubeqa royalties jump

Orion Q3 operating profit beats forecasts as Nubeqa royalties jump

Alurion Resources Quarterly Activities Report - September 2026

Alurion Resources Quarterly Activities Report - September 2026

Mobilize your Website

View Site in Mobile | Classic

Share by: